Propanc Biopharma, Inc. (PPCB) › Shareholders' EquityPropanc Biopharma, Inc. (PPCB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $85.1K2009: -$409.4K2010: -$186.9K2011: $10.51M2012: -$537.9K2013: -$792.5K2014: -$1.41M2015: -$3.05M2016: -$2.57M2017: -$5.44M2018: -$6.75M2019: -$4.30M2020: -$3.64M2021: -$3.07M2022: -$3.02M2023: -$3.12M2024: -$3.78M2025: $13.91M$13.91M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$13.91M+468.0%2024-$3.78M-21.2%2023-$3.12M-3.1%2022-$3.02M+1.4%2021-$3.07M+15.8%2020-$3.64M+15.3%2019-$4.30M+36.3%2018-$6.75M-24.1%2017-$5.44M-112.1%2016-$2.57M+16.0%2015-$3.05M-116.8%2014-$1.41M-77.7%2013-$792.5K-47.3%2012-$537.9K-105.1%2011$10.51M+5721.8%2010-$186.9K+54.3%2009-$409.4K-580.9%2008$85.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share